We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+6.07%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.05B
AUM Growth
+$503M
Cap. Flow
+$454M
Cap. Flow %
11.2%
Top 10 Hldgs %
55.84%
Holding
654
New
120
Increased
131
Reduced
191
Closed
155

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$269M
2
SRCL
Stericycle Inc
SRCL
+$141M
3
MRO
Marathon Oil Corporation
MRO
+$108M
4
CHX
ChampionX
CHX
+$103M
5
SPR
Spirit AeroSystems
SPR
+$95.3M

Top Sells

Rank Stock Value
1
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
+$149M
2
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$81.8M
3
SWN
Southwestern Energy Company
SWN
+$56.7M
4
UNP icon
Union Pacific
UNP
+$24.2M
5
X
US Steel
X
+$20.2M

Sector Composition

Rank Sector Weight
1 Energy 20.91%
2 Technology 19.62%
3 Healthcare 14.36%
4 Industrials 11.13%
5 Consumer Staples 9.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BE icon
376
Bloom Energy
BE
$64.2B
$211K 0.01%
+20,000
New +$237K
INSP icon
377
Inspire Medical Systems
INSP
$1.73B
$211K 0.01%
1,000
-3,585
-78% -$623K
DV icon
378
DoubleVerify
DV
$2.04B
$211K 0.01%
+12,500
New +$238K
LTC
379
LTC Properties
LTC
$2.13B
$210K 0.01%
5,716
-15,138
-73% -$549K
MGNI icon
380
CALL
Magnite
MGNI
$3.63B
$198K ﹤0.01%
+107,000
New +$1.46M
ERAS icon
381
Erasca
ERAS
$6.36B
$191K ﹤0.01%
+70,000
New +$197K
BOLD
382
Boundless Bio
BOLD
$64.1M
$184K ﹤0.01%
+53,168
New +$193K
EVLVW
383
DELISTED
Evolv Technologies Warrant
EVLVW
$182K ﹤0.01%
463,341
-14,900
-3% -$5.92K
BGS icon
384
PUT
B&G Foods
BGS
$280M
$179K ﹤0.01%
117,500
– –
IMUX icon
385
Immunic
IMUX
$211M
$178K ﹤0.01%
10,769
-1,000
-8% -$14.2K
PTGX icon
386
CALL
Protagonist Therapeutics
PTGX
$9.49B
$164K ﹤0.01%
+40,000
New +$1.62M
SVRA icon
387
Savara
SVRA
$1.2B
$163K ﹤0.01%
38,482
-5,496
-12% -$24.3K
LVS icon
388
PUT
Las Vegas Sands
LVS
$29.3B
$158K ﹤0.01%
37,200
– –
STWD icon
389
PUT
Starwood Property Trust
STWD
$5.99B
$157K ﹤0.01%
138,100
– –
LYV icon
390
PUT
Live Nation Entertainment
LYV
$42.9B
$156K ﹤0.01%
215,400
– –
OMF icon
391
PUT
OneMain Financial
OMF
$7.46B
$137K ﹤0.01%
30,500
– –
ALT icon
392
Altimmune
ALT
$595M
$135K ﹤0.01%
22,048
-17,952
-45% -$122K
CCCC icon
393
C4 Therapeutics
CCCC
$409M
$131K ﹤0.01%
+23,000
New +$138K
CAR icon
394
CALL
Avis
CAR
$4.96B
$128K ﹤0.01%
+15,000
New +$1.35M
AGEN
395
Agenus
AGEN
$300M
$125K ﹤0.01%
22,888
-52,301
-70% -$391K
XBI icon
396
CALL
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$124K ﹤0.01%
135,000
+75,000
+125% +$7.37M
UBX
397
DELISTED
Unity Biotechnology
UBX
$117K ﹤0.01%
79,354
+7,371
+10% +$10.8K
DTIL icon
398
Precision BioSciences
DTIL
$208M
$114K ﹤0.01%
12,729
+1,183
+10% +$11.4K
SLNO
399
CALL
DELISTED
Soleno Therapeutics
SLNO
$108K ﹤0.01%
+28,000
New +$1.34M
XBI icon
400
PUT
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$106K ﹤0.01%
+70,000
New +$6.88M
14 15
16
17 18

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q3 2024 Portfolio in Review

As of Q3 2024, UBS O'Connor held 654 positions worth $4.05B, up 14% from $3.55B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

UBS O'Connor deployed $454M of net new capital in Q3 2024, opening 120 new positions and adding to 131 existing holdings. Its largest new stake was Kellanova: 3,778,689 shares worth $305M.

By sector, the portfolio is most concentrated in Energy at 21% of assets, down from 27% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was US Steel, an estimated $20.2M trimmed.

  • UBS O'Connor's largest Q3 2024 buy was Kellanova: 3,778,689 shares worth $305M.
  • UBS O'Connor added most to Stericycle Inc in Q3 2024, an estimated $141M increase.
  • UBS O'Connor's biggest Q3 2024 reduction was US Steel, cutting an estimated $20.2M.
  • UBS O'Connor fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $149M.
  • UBS O'Connor's ten largest holdings make up 56% of its $4.05B portfolio in Q3 2024.
  • UBS O'Connor opened 120 new positions and closed 155 in Q3 2024.
  • UBS O'Connor's portfolio value rose 14% quarter-over-quarter to $4.05B.

Based on UBS O'Connor's 13F filing for Q3 2024, filed 14 Nov 2024.